View Future GrowthDenka 過去の業績過去 基準チェック /06Denkaの収益は年間平均-48.8%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間4% 1.7%割合で 増加しています。主要情報-48.80%収益成長率-48.80%EPS成長率Chemicals 業界の成長12.93%収益成長率1.68%株主資本利益率-5.54%ネット・マージン-2.40%前回の決算情報31 Dec 2025最近の業績更新お知らせ • Apr 22+ 3 more updatesDenka Company Limited to Report Q2, 2027 Results on Nov 09, 2026Denka Company Limited announced that they will report Q2, 2027 results on Nov 09, 2026お知らせ • Dec 24Denka Company Limited to Report Q3, 2026 Results on Feb 06, 2026Denka Company Limited announced that they will report Q3, 2026 results on Feb 06, 2026お知らせ • Sep 03Denka Company Limited to Report Q2, 2026 Results on Nov 10, 2025Denka Company Limited announced that they will report Q2, 2026 results on Nov 10, 2025お知らせ • Jul 02Denka Company Limited to Report Q1, 2026 Results on Aug 07, 2025Denka Company Limited announced that they will report Q1, 2026 results on Aug 07, 2025お知らせ • Dec 03Denka Company Limited to Report Q3, 2025 Results on Feb 07, 2025Denka Company Limited announced that they will report Q3, 2025 results on Feb 07, 2025お知らせ • Sep 27Denka Company Limited to Report Q2, 2025 Results on Nov 08, 2024Denka Company Limited announced that they will report Q2, 2025 results on Nov 08, 2024すべての更新を表示Recent updatesお知らせ • May 13Denka Company Limited, Annual General Meeting, Jun 19, 2026Denka Company Limited, Annual General Meeting, Jun 19, 2026.お知らせ • Apr 22+ 3 more updatesDenka Company Limited to Report Q2, 2027 Results on Nov 09, 2026Denka Company Limited announced that they will report Q2, 2027 results on Nov 09, 2026お知らせ • Mar 26Denka Company Limited (TSE:4061) completed the acquisition of 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders.Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion on February 6, 2026. A cash consideration of ¥7.89 billion valued at ¥2285 per share will be paid by Denka Company Limited. As part of consideration, ¥7.89 billion is paid towards common equity of KAINOS Laboratories, Inc. Denka Company Limited intends to launch a Squeeze-Out Procedures, if it acquires the minimum tender shares (1,990,000 shares) and fails to acquire all of the KAINOS Laboratories, Inc's Shares (excluding the Shares Agreed Not to Be Tendered and treasury shares). The transaction is subject to minimum tender. The expected completion of the transaction is March 25, 2026. Sumitomo Mitsui Banking Corporation acted as financial advisor for Denka Company Limited. AGS Consulting Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Nagashima Ohno & Tsunematsu acted as legal advisor for KAINOS Laboratories, Inc. TMI Associates acted as legal advisor for KAINOS Laboratories, Inc. Mizuho Securities Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Denka Company Limited (TSE:4061) completed the acquisition of 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders on March 25, 2026. Upon closing of the offer period, 3,223,919 shares were tendered. Since it is more than the minimum number of shares to be purchased (1,990,000 shares), Denka Company Limited will purchase all of the Tendered Share Certificates and intends to implement a series of procedures for the purpose of making the Tender Offeror the sole shareholder of KAINOS Laboratories, Inc. As of today, the KAINOS Laboratories, Inc's Shares are listed on the Standard Market of the Tokyo Stock Exchange. If the procedures are implemented, the KAINOS Laboratories, Inc's Shares will be delisted pursuant to the prescribed procedures, in accordance with the criteria for delisting of Tokyo Stock Exchange. KAINOS Laboratories, Inc's Shares, after being delisted, will no longer be traded on the Standard Market of the Tokyo Stock Exchange.お知らせ • Mar 10Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202).Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202) on March 9, 2026. Upon completion, Denka Company Limited will own 65% stake in Toyo Styrene Co. Ltd. As a result of this transaction, Toyo Styrene is expected to become a consolidated subsidiary of the Company that qualifies as a specified subsidiary. Daicel will cease to be a co-investor in Toyo Styrene, and Toyo Styrene’s Hirohata Plant will be shut down. For a certain period, however, Toyo Styrene will continue to outsource production to Daicel and maintain product sales. For the period ending March 31, 2025, Toyo Styrene Co. Ltd reported total revenue of ¥48.39 billion, EBIT of ¥1.22 billion and net income of ¥788 million. As of March 31, 2025, Toyo Styrene Co. Ltd reported total assets of ¥27.69 billion and total common equity of ¥11.73 billion. The completion of this share transfer is subject to the completion of the necessary approvals, permissions, or clearances from the relevant authorities in accordance with the Anti-Monopoly Act and other applicable laws and regulations. The expected completion of the transaction is March 31, 2026.お知らせ • Feb 09Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion.Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion on February 6, 2026. A cash consideration of ¥7.89 billion valued at ¥2285 per share will be paid by Denka Company Limited. As part of consideration, ¥7.89 billion is paid towards common equity of KAINOS Laboratories, Inc. The transaction is subject to minimum tender. The expected completion of the transaction is March 25, 2026. Sumitomo Mitsui Banking Corporation acted as financial advisor for Denka Company Limited. AGS Consulting Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Nagashima Ohno & Tsunematsu acted as legal advisor for KAINOS Laboratories, Inc. TMI Associates acted as legal advisor for KAINOS Laboratories, Inc. Mizuho Securities Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc.お知らせ • Dec 24Denka Company Limited to Report Q3, 2026 Results on Feb 06, 2026Denka Company Limited announced that they will report Q3, 2026 results on Feb 06, 2026お知らせ • Sep 22Denka Company Limited(TSE:4061) dropped from FTSE All-World Index (USD)Denka Company Limited(TSE:4061) dropped from FTSE All-World Index (USD)お知らせ • Sep 03Denka Company Limited to Report Q2, 2026 Results on Nov 10, 2025Denka Company Limited announced that they will report Q2, 2026 results on Nov 10, 2025お知らせ • Jul 02Denka Company Limited to Report Q1, 2026 Results on Aug 07, 2025Denka Company Limited announced that they will report Q1, 2026 results on Aug 07, 2025お知らせ • May 13+ 3 more updatesDenka Company Limited, Annual General Meeting, Jun 20, 2025Denka Company Limited, Annual General Meeting, Jun 20, 2025.お知らせ • Mar 12Oriental Shiraishi Corporation (TSE:1786) signed a share transfer agreement to acquire 51% stake in Denka Renotec Co., Ltd. from Denka Company Limited (TSE:4061).Oriental Shiraishi Corporation (TSE:1786) signed a share transfer agreement to acquire 51% stake in Denka Renotec Co., Ltd. from Denka Company Limited (TSE:4061) on March 12, 2025. Even after the transfer of shares, Denka Renotec will remain an equity-method affiliate of Denka Company Limited.お知らせ • Dec 03Denka Company Limited to Report Q3, 2025 Results on Feb 07, 2025Denka Company Limited announced that they will report Q3, 2025 results on Feb 07, 2025お知らせ • Sep 27Denka Company Limited to Report Q2, 2025 Results on Nov 08, 2024Denka Company Limited announced that they will report Q2, 2025 results on Nov 08, 2024お知らせ • Jun 15Denka Company Limited to Report Q1, 2025 Results on Aug 07, 2024Denka Company Limited announced that they will report Q1, 2025 results on Aug 07, 2024お知らせ • May 12Denka Company Limited, Annual General Meeting, Jun 20, 2024Denka Company Limited, Annual General Meeting, Jun 20, 2024.お知らせ • Apr 24Denka Company Limited (TSE:4061) agreed to acquire 50% stake in Frontier Carbon Corporation from Mitsubishi Corporation (TSE:8058).Denka Company Limited (TSE:4061) agreed to acquire 50% stake in Frontier Carbon Corporation from Mitsubishi Corporation (TSE:8058) on April 24, 2024.お知らせ • Mar 02Denka Company Limited to Report Fiscal Year 2024 Results on May 10, 2024Denka Company Limited announced that they will report fiscal year 2024 results on May 10, 2024お知らせ • Dec 09Denka Company Limited to Report Q3, 2024 Results on Feb 07, 2024Denka Company Limited announced that they will report Q3, 2024 results on Feb 07, 2024お知らせ • Sep 02Denka Company Limited to Report Q2, 2024 Results on Nov 08, 2023Denka Company Limited announced that they will report Q2, 2024 results on Nov 08, 2023お知らせ • Jun 09Denka Company Limited to Report Q1, 2024 Results on Aug 07, 2023Denka Company Limited announced that they will report Q1, 2024 results on Aug 07, 2023お知らせ • May 13Denka Company Limited, Annual General Meeting, Jun 22, 2023Denka Company Limited, Annual General Meeting, Jun 22, 2023.お知らせ • Nov 27Denka Company Limited to Report Q3, 2023 Results on Feb 07, 2023Denka Company Limited announced that they will report Q3, 2023 results on Feb 07, 2023収支内訳Denka の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:DENK.F 収益、費用、利益 ( )JPY Millions日付収益収益G+A経費研究開発費31 Dec 25389,427-9,34268,565030 Sep 25397,896-11,77057,99212,44530 Jun 25399,091-9,54970,559031 Mar 25400,251-12,30057,73712,44531 Dec 24398,01810,94258,86912,68030 Sep 24396,9488,76057,18812,68030 Jun 24396,66111,90256,92312,68031 Mar 24389,26311,94756,44412,68031 Dec 23391,6697,50854,79812,68030 Sep 23396,0005,00055,56712,68030 Jun 23401,01910,72656,15912,68031 Mar 23407,55912,76857,33712,68031 Dec 22409,60511,94357,72511,94730 Sep 22396,63422,29457,27311,94730 Jun 22392,49124,19356,62511,94731 Mar 22384,84926,01255,10411,94731 Dec 21376,38326,80654,76312,50130 Sep 21385,23230,82254,41412,50130 Jun 21364,88524,75153,67312,50131 Mar 21354,39122,78552,96312,50131 Dec 20354,13324,89353,15912,61930 Sep 20349,15221,85953,65512,61930 Jun 20366,15221,87554,58812,61931 Mar 20380,80322,70355,13112,61931 Dec 19391,49923,32455,30211,98630 Sep 19406,73324,50855,60211,98630 Jun 19410,04323,83655,91711,98631 Mar 19413,12825,04656,07411,98631 Dec 18412,78322,51057,16911,47730 Sep 18406,13422,15056,15211,47730 Jun 18399,01023,22055,75111,47731 Mar 18395,62923,03554,91711,47731 Dec 17389,03723,53854,65811,10230 Sep 17378,68424,30653,93911,10230 Jun 17371,25121,95652,76711,10231 Mar 17362,64718,14552,43711,10231 Dec 16359,13417,16253,2579,65630 Sep 16359,03215,70152,5009,65630 Jun 16364,90817,33852,1869,65631 Mar 16369,85319,47251,4989,65631 Dec 15372,60121,03250,9758,79630 Sep 15379,73521,38350,4338,79630 Jun 15384,05121,36249,0708,79631 Mar 15383,97819,02148,7538,796質の高い収益: DENK.Fは現在利益が出ていません。利益率の向上: DENK.Fは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: DENK.Fは利益が出ておらず、過去 5 年間で損失は年間48.8%の割合で増加しています。成長の加速: DENK.Fの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: DENK.Fは利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( 0.1% ) と比較することは困難です。株主資本利益率高いROE: DENK.Fは現在利益が出ていないため、自己資本利益率 ( -5.54% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/03/03 11:09終値2025/12/04 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Denka Company Limited 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。14 アナリスト機関Takashi EnomotoBofA Global ResearchAtsushi IkedaCitigroup IncHidemitsu UmebayashiDaiwa Securities Co. Ltd.11 その他のアナリストを表示
お知らせ • Apr 22+ 3 more updatesDenka Company Limited to Report Q2, 2027 Results on Nov 09, 2026Denka Company Limited announced that they will report Q2, 2027 results on Nov 09, 2026
お知らせ • Dec 24Denka Company Limited to Report Q3, 2026 Results on Feb 06, 2026Denka Company Limited announced that they will report Q3, 2026 results on Feb 06, 2026
お知らせ • Sep 03Denka Company Limited to Report Q2, 2026 Results on Nov 10, 2025Denka Company Limited announced that they will report Q2, 2026 results on Nov 10, 2025
お知らせ • Jul 02Denka Company Limited to Report Q1, 2026 Results on Aug 07, 2025Denka Company Limited announced that they will report Q1, 2026 results on Aug 07, 2025
お知らせ • Dec 03Denka Company Limited to Report Q3, 2025 Results on Feb 07, 2025Denka Company Limited announced that they will report Q3, 2025 results on Feb 07, 2025
お知らせ • Sep 27Denka Company Limited to Report Q2, 2025 Results on Nov 08, 2024Denka Company Limited announced that they will report Q2, 2025 results on Nov 08, 2024
お知らせ • May 13Denka Company Limited, Annual General Meeting, Jun 19, 2026Denka Company Limited, Annual General Meeting, Jun 19, 2026.
お知らせ • Apr 22+ 3 more updatesDenka Company Limited to Report Q2, 2027 Results on Nov 09, 2026Denka Company Limited announced that they will report Q2, 2027 results on Nov 09, 2026
お知らせ • Mar 26Denka Company Limited (TSE:4061) completed the acquisition of 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders.Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion on February 6, 2026. A cash consideration of ¥7.89 billion valued at ¥2285 per share will be paid by Denka Company Limited. As part of consideration, ¥7.89 billion is paid towards common equity of KAINOS Laboratories, Inc. Denka Company Limited intends to launch a Squeeze-Out Procedures, if it acquires the minimum tender shares (1,990,000 shares) and fails to acquire all of the KAINOS Laboratories, Inc's Shares (excluding the Shares Agreed Not to Be Tendered and treasury shares). The transaction is subject to minimum tender. The expected completion of the transaction is March 25, 2026. Sumitomo Mitsui Banking Corporation acted as financial advisor for Denka Company Limited. AGS Consulting Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Nagashima Ohno & Tsunematsu acted as legal advisor for KAINOS Laboratories, Inc. TMI Associates acted as legal advisor for KAINOS Laboratories, Inc. Mizuho Securities Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Denka Company Limited (TSE:4061) completed the acquisition of 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders on March 25, 2026. Upon closing of the offer period, 3,223,919 shares were tendered. Since it is more than the minimum number of shares to be purchased (1,990,000 shares), Denka Company Limited will purchase all of the Tendered Share Certificates and intends to implement a series of procedures for the purpose of making the Tender Offeror the sole shareholder of KAINOS Laboratories, Inc. As of today, the KAINOS Laboratories, Inc's Shares are listed on the Standard Market of the Tokyo Stock Exchange. If the procedures are implemented, the KAINOS Laboratories, Inc's Shares will be delisted pursuant to the prescribed procedures, in accordance with the criteria for delisting of Tokyo Stock Exchange. KAINOS Laboratories, Inc's Shares, after being delisted, will no longer be traded on the Standard Market of the Tokyo Stock Exchange.
お知らせ • Mar 10Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202).Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202) on March 9, 2026. Upon completion, Denka Company Limited will own 65% stake in Toyo Styrene Co. Ltd. As a result of this transaction, Toyo Styrene is expected to become a consolidated subsidiary of the Company that qualifies as a specified subsidiary. Daicel will cease to be a co-investor in Toyo Styrene, and Toyo Styrene’s Hirohata Plant will be shut down. For a certain period, however, Toyo Styrene will continue to outsource production to Daicel and maintain product sales. For the period ending March 31, 2025, Toyo Styrene Co. Ltd reported total revenue of ¥48.39 billion, EBIT of ¥1.22 billion and net income of ¥788 million. As of March 31, 2025, Toyo Styrene Co. Ltd reported total assets of ¥27.69 billion and total common equity of ¥11.73 billion. The completion of this share transfer is subject to the completion of the necessary approvals, permissions, or clearances from the relevant authorities in accordance with the Anti-Monopoly Act and other applicable laws and regulations. The expected completion of the transaction is March 31, 2026.
お知らせ • Feb 09Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion.Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion on February 6, 2026. A cash consideration of ¥7.89 billion valued at ¥2285 per share will be paid by Denka Company Limited. As part of consideration, ¥7.89 billion is paid towards common equity of KAINOS Laboratories, Inc. The transaction is subject to minimum tender. The expected completion of the transaction is March 25, 2026. Sumitomo Mitsui Banking Corporation acted as financial advisor for Denka Company Limited. AGS Consulting Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Nagashima Ohno & Tsunematsu acted as legal advisor for KAINOS Laboratories, Inc. TMI Associates acted as legal advisor for KAINOS Laboratories, Inc. Mizuho Securities Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc.
お知らせ • Dec 24Denka Company Limited to Report Q3, 2026 Results on Feb 06, 2026Denka Company Limited announced that they will report Q3, 2026 results on Feb 06, 2026
お知らせ • Sep 22Denka Company Limited(TSE:4061) dropped from FTSE All-World Index (USD)Denka Company Limited(TSE:4061) dropped from FTSE All-World Index (USD)
お知らせ • Sep 03Denka Company Limited to Report Q2, 2026 Results on Nov 10, 2025Denka Company Limited announced that they will report Q2, 2026 results on Nov 10, 2025
お知らせ • Jul 02Denka Company Limited to Report Q1, 2026 Results on Aug 07, 2025Denka Company Limited announced that they will report Q1, 2026 results on Aug 07, 2025
お知らせ • May 13+ 3 more updatesDenka Company Limited, Annual General Meeting, Jun 20, 2025Denka Company Limited, Annual General Meeting, Jun 20, 2025.
お知らせ • Mar 12Oriental Shiraishi Corporation (TSE:1786) signed a share transfer agreement to acquire 51% stake in Denka Renotec Co., Ltd. from Denka Company Limited (TSE:4061).Oriental Shiraishi Corporation (TSE:1786) signed a share transfer agreement to acquire 51% stake in Denka Renotec Co., Ltd. from Denka Company Limited (TSE:4061) on March 12, 2025. Even after the transfer of shares, Denka Renotec will remain an equity-method affiliate of Denka Company Limited.
お知らせ • Dec 03Denka Company Limited to Report Q3, 2025 Results on Feb 07, 2025Denka Company Limited announced that they will report Q3, 2025 results on Feb 07, 2025
お知らせ • Sep 27Denka Company Limited to Report Q2, 2025 Results on Nov 08, 2024Denka Company Limited announced that they will report Q2, 2025 results on Nov 08, 2024
お知らせ • Jun 15Denka Company Limited to Report Q1, 2025 Results on Aug 07, 2024Denka Company Limited announced that they will report Q1, 2025 results on Aug 07, 2024
お知らせ • May 12Denka Company Limited, Annual General Meeting, Jun 20, 2024Denka Company Limited, Annual General Meeting, Jun 20, 2024.
お知らせ • Apr 24Denka Company Limited (TSE:4061) agreed to acquire 50% stake in Frontier Carbon Corporation from Mitsubishi Corporation (TSE:8058).Denka Company Limited (TSE:4061) agreed to acquire 50% stake in Frontier Carbon Corporation from Mitsubishi Corporation (TSE:8058) on April 24, 2024.
お知らせ • Mar 02Denka Company Limited to Report Fiscal Year 2024 Results on May 10, 2024Denka Company Limited announced that they will report fiscal year 2024 results on May 10, 2024
お知らせ • Dec 09Denka Company Limited to Report Q3, 2024 Results on Feb 07, 2024Denka Company Limited announced that they will report Q3, 2024 results on Feb 07, 2024
お知らせ • Sep 02Denka Company Limited to Report Q2, 2024 Results on Nov 08, 2023Denka Company Limited announced that they will report Q2, 2024 results on Nov 08, 2023
お知らせ • Jun 09Denka Company Limited to Report Q1, 2024 Results on Aug 07, 2023Denka Company Limited announced that they will report Q1, 2024 results on Aug 07, 2023
お知らせ • May 13Denka Company Limited, Annual General Meeting, Jun 22, 2023Denka Company Limited, Annual General Meeting, Jun 22, 2023.
お知らせ • Nov 27Denka Company Limited to Report Q3, 2023 Results on Feb 07, 2023Denka Company Limited announced that they will report Q3, 2023 results on Feb 07, 2023